Ovarian, fallopian tube and peritoneal cancer (BRCA 1 or 2, mutated, relapsed, platinum-sensitive) - olaparib (maintenance) [ID735]
Status Complete
Process STA
Referral date July 2014

Scoped as part of Batch 36


Key events during the development of the guidance:

Date Update
27 January 2016 Expected publication
27 January 2016 Guidance published
11 December 2015 - 04 January 2016 Final appraisal determination
24 September 2015 Please note that due to administrative requirements, the next committee meeting for the above appraisal has been postponed from 29 September to 27 October 2015.

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance